Acurx Pharmaceuticals Director Joseph C. Scodari Retires From Board Effective Nov. 13

PUBT · 1d ago
Acurx Pharmaceuticals Director Joseph C. Scodari Retires From Board Effective Nov. 13
  • Acurx Pharmaceuticals director Joseph C. Scodari gave notice Nov. 12, 2026, of his retirement effective Nov. 13, 2026.
  • Scodari, a board member since 2021, will serve as a corporate advisor following his retirement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-127104), on November 13, 2026, and is solely responsible for the information contained therein.